JP2021535170A5 - - Google Patents
Info
- Publication number
- JP2021535170A5 JP2021535170A5 JP2021511602A JP2021511602A JP2021535170A5 JP 2021535170 A5 JP2021535170 A5 JP 2021535170A5 JP 2021511602 A JP2021511602 A JP 2021511602A JP 2021511602 A JP2021511602 A JP 2021511602A JP 2021535170 A5 JP2021535170 A5 JP 2021535170A5
- Authority
- JP
- Japan
- Prior art keywords
- vol
- approximately
- composition
- composition according
- amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024125762A JP2024170397A (ja) | 2018-08-31 | 2024-08-01 | 薬物送達のための相乗的な透過促進剤を伴う組成物 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862726058P | 2018-08-31 | 2018-08-31 | |
| US62/726,058 | 2018-08-31 | ||
| US201962814161P | 2019-03-05 | 2019-03-05 | |
| US62/814,161 | 2019-03-05 | ||
| PCT/US2019/049084 WO2020047422A1 (en) | 2018-08-31 | 2019-08-30 | Compositions with synergistic permeation enhancers for drug delivery |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024125762A Division JP2024170397A (ja) | 2018-08-31 | 2024-08-01 | 薬物送達のための相乗的な透過促進剤を伴う組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021535170A JP2021535170A (ja) | 2021-12-16 |
| JP2021535170A5 true JP2021535170A5 (enExample) | 2022-08-22 |
| JP7534284B2 JP7534284B2 (ja) | 2024-08-14 |
Family
ID=69642825
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021511602A Active JP7534284B2 (ja) | 2018-08-31 | 2019-08-30 | 薬物送達のための相乗的な透過促進剤を伴う組成物 |
| JP2024125762A Pending JP2024170397A (ja) | 2018-08-31 | 2024-08-01 | 薬物送達のための相乗的な透過促進剤を伴う組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024125762A Pending JP2024170397A (ja) | 2018-08-31 | 2024-08-01 | 薬物送達のための相乗的な透過促進剤を伴う組成物 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20210322396A1 (enExample) |
| EP (1) | EP3843785A4 (enExample) |
| JP (2) | JP7534284B2 (enExample) |
| CA (1) | CA3110566A1 (enExample) |
| WO (1) | WO2020047422A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HK1252531A1 (zh) | 2015-08-05 | 2019-05-31 | Children's Medical Center Corporation | 用於药物递送的具有渗透增强剂的组合物 |
| CN118121541B (zh) * | 2024-03-14 | 2025-09-16 | 江西省保灵动物保健品有限公司 | 一种盐酸特比萘芬喷雾剂的制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU7389098A (en) * | 1997-05-16 | 1998-12-08 | Brigham And Women's Hospital | Local anesthetic formulations |
| WO2009143174A2 (en) * | 2008-05-19 | 2009-11-26 | Children's Medical Center Corporation | Chemical permeation enhancers enhance nerve blockade by toxins |
| US9505737B2 (en) * | 2013-01-11 | 2016-11-29 | Corsair Pharma, Inc. | Treprostinil derivative compounds and methods of using same |
| HK1252531A1 (zh) * | 2015-08-05 | 2019-05-31 | Children's Medical Center Corporation | 用於药物递送的具有渗透增强剂的组合物 |
-
2019
- 2019-08-30 CA CA3110566A patent/CA3110566A1/en active Pending
- 2019-08-30 EP EP19853899.3A patent/EP3843785A4/en not_active Withdrawn
- 2019-08-30 US US17/272,212 patent/US20210322396A1/en active Pending
- 2019-08-30 JP JP2021511602A patent/JP7534284B2/ja active Active
- 2019-08-30 WO PCT/US2019/049084 patent/WO2020047422A1/en not_active Ceased
-
2024
- 2024-08-01 JP JP2024125762A patent/JP2024170397A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5714512B2 (ja) | 哺乳動物の内耳及び外耳の感染症の治療に有用な耳科用組成物 | |
| ES2542847T3 (es) | Formulaciones que comprenden capsaicina, un anestésico local y/o un agente antipruriginoso para el tratamiento del dolor | |
| JP6539444B2 (ja) | 安定なポビドンヨード組成物 | |
| JP2018522905A5 (enExample) | ||
| JP2019194191A5 (enExample) | ||
| JP2014516954A5 (enExample) | ||
| JP2005511564A5 (enExample) | ||
| JP2019529541A5 (enExample) | ||
| CN102316863B (zh) | 5-苄基氨基水杨酸衍生物或其盐的医药用途 | |
| CA2465132A1 (en) | Vaginally administered anti-dysrhythmic agents for treating pelvic pain | |
| JP2021535170A5 (enExample) | ||
| JP2021073257A5 (enExample) | ||
| JP2020524689A5 (enExample) | ||
| PH12022551798A1 (en) | Use of benzoate compound in treatment of sars-cov-2 infection | |
| JP2020536048A5 (enExample) | ||
| NZ753781A (en) | Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of use | |
| JP2023549849A5 (enExample) | ||
| WO2018217139A4 (ru) | Новые ингибиторы глутаминилциклаз и их применение для лечения различных заболеваний | |
| JP2025507472A5 (enExample) | ||
| TW200902093A (en) | N-halogenated amino acid formulations | |
| JPH11228387A (ja) | ヨード系殺菌剤を含有する薬用組成物 | |
| EA201991188A1 (ru) | Новые ингибиторы глутаминилциклаз и их применение для лечения различных заболеваний | |
| JP2018532807A5 (enExample) | ||
| AU2020201113A1 (en) | Antimicrobial compositions and methods of use | |
| TW200902092A (en) | Aliphatic acid-containing N-halogenated amino acid formulations |